Identification of Alternative Splice Variants Using Unique Tryptic Peptide Sequences for Database Searches

Area of Science:

• Molecular Biology
• Proteomics
• Bioinformatics

Background:

• Alternative splicing generates diverse messenger RNA (mRNA) isoforms from a single gene in eukaryotes.
• Identifying these splice variants necessitates the detection of unique peptides specific to each form.
• Current methods require specialized databases for accurate splice variant identification.

Purpose of the Study:

• To develop and validate a human database containing unique tryptic peptides specific to alternative splice forms.
• To facilitate the identification of splice variant-specific peptides from mass spectrometry (MS) data.
• To enable comprehensive analysis of alternative splicing events in different biological contexts.

Main Methods:

• Generation of a human database comprising unique tryptic peptides specific for alternative splice forms from Swiss-Prot.
• Creation of a combined database by integrating the alternative splice variant-specific peptide database with the general human Swiss-Prot database.
• Analysis of liquid chromatography-mass spectrometry (LC-MS) data from LNCaP and HeLa cell lines, as well as phosphoproteomics studies.

Main Results:

• The specialized database provided easy access to splice variant-specific peptide sequences matching MS data.
• Analysis of cell line data revealed several non-alternative splice variant-1-specific peptides, some exhibiting cell-line specificity.
• Investigation of phosphoproteomes in Jurkat T cells identified non-alternative splice variant-1-specific peptides with significant quantitative differences between control and apoptotic states.

Conclusions:

• The developed human database effectively aids in the identification of alternative splicing variants.
• The approach is applicable to analyzing complex proteomic and phosphoproteomic datasets.
• This methodology enhances the discovery of splice variant-specific peptides and their potential biological significance.